Updated:
K2 Investment Partners
K2 Investment Partners is a private equity firm founded in 2011 in Seoul, South Korea. It invests in electronics, software, chemicals, biotechnology, and...
K2 Investment Partners
K2 Investment Partners is a private equity firm founded in 2011 in Seoul, South Korea. It invests in electronics, software, chemicals, biotechnology, and medical devices sectors. The firm has made 72 investments, including a Series A investment in BAT on February 03, 2026, and has achieved 7 portfolio exits, with IMBiologics exiting on March 20, 2026.
General information
Firm type
Private Equity
Year founded
1999
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Principals
Park Young-sik
CEO
Sector focus
Frequently asked questions
Who runs investment decisions at K2 Investment Partners?
Park Young-sik, the founder and CEO, leads the investment team. He has guided the firm's investment strategy since its founding in 1999, establishing K2 as one of South Korea's longer-running independent venture capital firms.
What investment stages does K2 Investment Partners typically target?
The firm deploys across early-stage, expansion, and pre-IPO rounds. It also engages in secondary transactions, positioning itself to invest flexibly throughout a company's growth lifecycle.
Which sectors does K2 Investment Partners focus on?
The firm maintains a multi-sector mandate that includes enterprise software, industrial technology, digital health, consumer, and fintech. Notable portfolio companies include Medytox in biopharmaceuticals and Techwing in semiconductor equipment.
Does K2 Investment Partners participate in fund commitments or only direct deals?
K2 Investment Partners operates through its own managed venture funds, making direct investments into companies rather than allocating to external fund commitments. The firm raises capital from domestic Korean institutional investors.
How is K2 Investment Partners positioned within the Korean VC ecosystem?
K2 is among the earliest cohort of independent Korean venture capital firms, operating continuously since the late 1990s. Unlike many peers that were acquired by or spun out from larger financial groups, the firm has maintained its independent ownership structure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: